Type-Specific Risk Factors and Outcome in an Outbreak With 2 Different Clostridium difficile Types Simultaneously in 1 Hospital

被引:54
作者
Goorhuis, A. [1 ]
Debast, S. B. [2 ]
Dutilh, J. C. [3 ]
van Kinschot, C. M. [1 ]
Harmanus, C. [1 ]
Cannegieter, S. C. [4 ]
Hagen, E. C. [3 ]
Kuijper, E. J. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Med Microbiol, Amersfoort, Netherlands
[2] Meander Med Ctr, Dept Med Microbiol, Amersfoort, Netherlands
[3] Meander Med Ctr, Dept Internal Med, Amersfoort, Netherlands
[4] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
关键词
HYPERVIRULENT STRAIN; NOSOCOMIAL OUTBREAK; SEVERE-DISEASE; DIARRHEA; INFECTION; EPIDEMIC; PCR; PREVALENCE; MORBIDITY;
D O I
10.1093/cid/cir549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Clostridium difficile infection (CDI) due to polymerase chain reaction (PCR) ribotype 027 (type 027) has been described worldwide. In some countries, an increase was reported of toxin A-negative PCR ribotype 017 (type 017). We encountered an outbreak due to these 2 types occurring simultaneously in a 980-bed teaching hospital in the Netherlands. Methods. In a case-control study from May 2005 through January 2007, we investigated general and type-specific risk factors as well as outcome parameters for CDI due to type 027 or 017. Clonal dissemination was investigated by multilocus variable number of tandem repeat analysis (MLVA). Results. We identified 168 CDI patients: 57 (34%) with type 017, 46 (27%) with type 027, and 65 (39%) with 1 of 36 different other types. As controls, we included 77 non-CDI diarrheal patients and 162 patients without diarrhea. Risk factors for CDI were nasogastric intubation, recent hospitalization, and use of cephalosporins and clindamycin. Type-specific risk factors were older age for both types 017 and 027, use of clindamycin and immunosuppressive agents for type 017, and use of fluoroquinolones for type 027. At day 30 of follow-up, the overall mortality among patients with types 017, 027, other types, non-CDI diarrheal patients, and nondiarrheal patients was 23%, 26%, 3%, 2%, and 6%, respectively. MLVA showed persistent clonal dissemination of types 017 and 027, despite appropriate infection control measures. Conclusions. Patients with CDI have type-specific risk factors and mortality rates, with prolonged clonal spread of type 027 or 017.
引用
收藏
页码:860 / 869
页数:10
相关论文
共 29 条
  • [1] Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea
    Alfa, MJ
    Kabani, A
    Lyerly, D
    Moncrief, S
    Neville, LM
    Al-Barrak, A
    Harding, GKH
    Dyck, B
    Olekson, K
    Embil, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) : 2706 - 2714
  • [2] Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates
    Barbut, F.
    Mastrantonio, P.
    Delmee, M.
    Brazier, J.
    Kuijper, E.
    Poxton, I.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) : 1048 - 1057
  • [3] Narrative review: The new epidemic of clostridium difficile-associated enteric disease
    Bartlett, John G.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) : 758 - 764
  • [4] Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile
    Bidet, P
    Lalande, V
    Salauze, B
    Burghoffer, B
    Avesani, V
    Delmée, M
    Rossier, A
    Barbut, F
    Petit, JC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) : 2484 - 2487
  • [5] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [6] Clostridium difficile Strain NAP-1 Is Not Associated With Severe Disease in a Nonepidemic Setting
    Cloud, Jeffrey
    Noddin, Laura
    Pressman, Amanda
    Hu, Mary
    Kelly, Ciaran
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (08) : 868 - 873
  • [7] Toxin A-negative, toxin B-positive Clostridium difficile
    Drudy, Denise
    Fanning, Seamus
    Kyne, Lorraine
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (01) : 5 - 10
  • [8] Fourteen-Genome Comparison Identifies DNA Markers for Severe-Disease-Associated Strains of Clostridium difficile
    Forgetta, Vincenzo
    Oughton, Matthew T.
    Marquis, Pascale
    Brukner, Ivan
    Blanchette, Ruth
    Haub, Kevin
    Magrini, Vince
    Mardis, Elaine R.
    Gerding, Dale N.
    Loo, Vivian G.
    Miller, Mark A.
    Mulvey, Michael R.
    Rupnik, Maja
    Dascal, Andre
    Dewar, Ken
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (06) : 2230 - 2238
  • [9] Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina
    Goorhuis, A.
    Legaria, M. C.
    van den Berg, R. J.
    Harmanus, C.
    Klaassen, C. H. W.
    Brazier, J. S.
    Lumelsky, G.
    Kuijper, E. J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) : 1080 - 1086
  • [10] GOORHUIS A, 2007, CLIN INFECT DIS, V45, P695, DOI DOI 10.1086/520984